Your browser doesn't support javascript.
loading
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer.
Bilich, Tatjana; Roerden, Malte; Maringer, Yacine; Nelde, Annika; Heitmann, Jonas S; Dubbelaar, Marissa L; Peter, Andreas; Hörber, Sebastian; Bauer, Jens; Rieth, Jonas; Wacker, Marcel; Berner, Fiamma; Flatz, Lukas; Held, Stefanie; Brossart, Peter; Märklin, Melanie; Wagner, Philipp; Erne, Eva; Klein, Reinhild; Rammensee, Hans-Georg; Salih, Helmut R; Walz, Juliane S.
Affiliation
  • Bilich T; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Roerden M; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Maringer Y; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany.
  • Nelde A; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Heitmann JS; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany.
  • Dubbelaar ML; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Peter A; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Hörber S; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Bauer J; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany.
  • Rieth J; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Wacker M; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Berner F; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany.
  • Flatz L; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Held S; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Brossart P; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Märklin M; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany.
  • Wagner P; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.
  • Erne E; Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Klein R; Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Rammensee HG; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Salih HR; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Walz JS; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany.
Cancer Discov ; 11(8): 1982-1995, 2021 08.
Article in En | MEDLINE | ID: mdl-34011563
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Discov Year: 2021 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Discov Year: 2021 Type: Article Affiliation country: Germany